VitaSpring Biomedical

VitaSpring Biomedical is a US-based biotechnology company specializing in regenerative medicine, located in Irvine, California. We are dedicated to pioneering innovative therapies utilizing placental-derived mesenchymal stem cells and exosomes, offering a novel approach to treating a wide range of diseases and promoting tissue regeneration.

Our core focus is on harnessing the remarkable healing properties of stem cells, particularly those sourced from the placenta, which retain maternal genetic information. We meticulously cultivate and process these cells into exosomes – tiny vesicles packed with therapeutic molecules – to deliver targeted regenerative signals directly to affected tissues.

VitaSpring Biomedical is committed to advancing the field of longevity medicine, investing heavily in research and development to establish advanced medical research centers and high-standard cell production centers, all while adhering to the FDA’s Good Tissue Practice (GTP) standard. We are currently exploring applications in acute lung injury, acute radiation injury, and multiple sclerosis, alongside cosmetic and anti-aging treatments. Our commitment to quality and innovation positions us as a key player in the future of cell-based therapies.